Tag Archives: Biogen

Heads up, Biogen. After digging into Tecfidera patent arguments, analyst predicts a loss

As Biogen preps for its closely watched aducanumab FDA filing in Alzheimer’s disease, a patent threat for the company’s top-selling medicine is causing concern for one team of analysts. In a note to clients Tuesday, Bernstein analyst Ronny Gal and his team downgraded Biogen’s stock—from outperform to market-perform—based on the belief that Mylan will win… Read More »

Viewpoints: Capitalism’s Cruel Cravings Fuel Vaping, Opioid Epidemics; Biogen Just Ditched Its Alzheimer’s Trial Participants By Pulling The Plug The First Time

Editorial writers focus on these health topics and others. Stat: Vaping And Prescription Opioids: Limbic Capitalism In Action  Have you ever written something and sent it off, only to encounter a perfect example of what you wanted to say? That happened to me. I had just finished a new book on addiction when the vaping… Read More »